Press releases
- Press releases
- Browse
Press releases
Life Science Leadership Series – Oncology
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
SkyePharma PLC licenses European marketing and distribution rights for DepoCyte, a treatment for lymphomatous meningitis, to Mundipharma More
Astex has successfully completed an initial Phase I trial of AT9283 in patients with refractory solid tumours and will be reporting key data at the ASCO Annual Meeting, May 29- June 2nd in Orlando, Florida. More
A dozen University of Western Ontario research projects, including ensuring innovative research on Metabolic Syndrome and personalized medicine, have received $19-million from the Ontario Research Fund. More
GP-Pharm S.A. today announced that it received orphan drug designation from the U.S. Food and Drug Administration (FDA) for SarcodoxomeTM, a new Liposomal formulation of doxorubicin hydrochloride, for the treatment of Soft Tissue Sarcoma (STS). More
The Wellcome Trust Limited and The Institute of Cancer Research announced a new alliance with GlaxoSmithKline to discover, develop and commercialize novel small molecule inhibitors of B-RAF for use as anti-cancer agent, More
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
Columbia University’s Science & Technology Ventures announced that it has signed a license agreement with Stockbridge Pharmaceuticals, Inc. to commercialize a novel small molecule-based approach, developed in collaboration with the University of Nebraska, More
Astex Therapeutics today announced that it had begun dosing first patients in a Phase I/IIa clinical trial of its investigational anti-cancer drug AT9283. More
The University of Western Ontario has given three research projects a financial boost to expedite efforts towards commercialization through the Western Innovation Fund (administered by WORLDiscoveries). More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 26 pages - $125
Dec 2010 - 19 pages - $99
Aug 2009 - $15,200
Aug 2010 - $15,200
Nov 2009 - 160 pages - $2,265
Jun 2011 - 34 pages - $125
Mar 2010 - $5,700
Feb 2008 - $2,500
Mar 2011 - 120 pages - $3,500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us